Cramer Remix: AbbVie and Biogen are the best-in-show biotechs for 2018 so far
January 31, 2018 at 19:00 PM EST
Jim Cramer breaks down his take on the biotech pullback and which two he thinks could be top performers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.